Hyperfine (HYPR) Retained Earnings (2020 - 2026)
Hyperfine (HYPR) posted Retained Earnings of $373.0 million for Q1 2026, up 213.02% on a QoQ basis from -$330.0 million in Q4 2025, and up 222.75% year-over-year from $115.6 million in Q1 2025.
Hyperfine (HYPR) Retained Earnings (2020 - 2026) Analysis & Trends
Hyperfine's Retained Earnings history runs 7 years deep, the most recent figure standing at $373.0 million for Q1 2026.
- Quarterly Retained Earnings rose 222.75% year-over-year to $373.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $373.0 million (up 222.75% YoY) and the FY2025 annual result came in at -$330.0 million, down 196.08% from the prior year.
- Retained Earnings was $373.0 million for Q1 2026 at Hyperfine, up from -$330.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $373.0 million in Q1 2026 and bottomed at -$330.0 million in Q4 2025.
- A 5-year average of $129.2 million and a median of $334.4 million in 2023 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 5619.38% in 2022, while the deepest fall reached 2392.52% in 2022.
- Hyperfine's Retained Earnings stood at -$209.5 million in 2022, then fell by 21.12% to -$253.7 million in 2023, then soared by 235.37% to $343.5 million in 2024, then slumped by 196.08% to -$330.0 million in 2025, then soared by 213.02% to $373.0 million in 2026.
- Business Quant data shows HYPR's Retained Earnings at $373.0 million in Q1 2026, -$330.0 million in Q4 2025, and $351.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 372.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 372.99 Mn |
| Dec 31, 2025 | -330.02 Mn |
| Sep 30, 2025 | 350.97 Mn |
| Jun 30, 2025 | 348.20 Mn |
| Mar 31, 2025 | -303.86 Mn |
| Dec 31, 2024 | 343.48 Mn |
| Sep 30, 2024 | -284.05 Mn |
| Jun 30, 2024 | 340.48 Mn |
| Mar 31, 2024 | 339.20 Mn |
| Dec 31, 2023 | -253.72 Mn |
| Sep 30, 2023 | 336.80 Mn |
| Jun 30, 2023 | 335.57 Mn |
| Mar 31, 2023 | 334.37 Mn |
| Dec 31, 2022 | -209.48 Mn |
| Sep 30, 2022 | 331.40 Mn |
| Jun 30, 2022 | -183.25 Mn |
| Mar 31, 2022 | 326.65 Mn |
| Dec 31, 2021 | -136.32 Mn |
| Sep 30, 2021 | -8.25 Mn |
| Jun 30, 2021 | -7.35 Mn |